+499.5%
MRNA vs ZCMD
-99.9%
+599.3%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ZCMD | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -3.8% | +1.5% | -2.2% |
| 7D | +5.5% | -8.0% | +13.5% | +5.5% |
| 30D | +158.7% | -27.9% | +186.6% | +159.5% |
| 3M | +182.1% | -74.6% | +256.7% | +186.0% |
| 6M | +151.8% | -99.5% | +251.3% | +176.8% |
| YTD | +393.6% | -99.7% | +493.3% | +485.9% |
| 1Y | +499.5% | -99.9% | +599.4% | +673.9% |
| All | +499.5% | -99.9% | +599.3% | +673.9% |
Cumulative growth
Daily Returns
Daily percentage return beside ZCMD.
Daily Out/Under-Performance
Portfolio return minus ZCMD return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ZCMD return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ZCMD wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling